COMP <GO>
TKNO vs ABBV // ALTMAN Z-SCORE & DEBT/EQUITY
Alpha Teknova Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: TKNO 1
— ABBV 10
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TKNO
LAST: $8.09 (+2.93%) • MKT CAP: $499.2M
balance-sheet
6.93
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
balance-sheet
5.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TKNO VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TKNO | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.20% | 70.20% | -37.00 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -21.30% | 29.00% | -50.30 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.96% | 3.47% | -5.43 | ABBV | /fcf-yield <GO> |
| Operating Margin | -41.90% | 24.60% | -66.50 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -42.60% | 6.90% | -49.50 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 7.40% | 8.60% | -1.20 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 6.93 | 5.33 | +1.60 | TKNO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.1 | 65.1 | -17.00 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 113.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $499.2M | $513.86B | -$513.36B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TKNO REV | ABBV REV | TKNO GROSS % | ABBV GROSS % | TKNO FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $40.5M | $61.16B | 33.2% | 70.2% | -$9.8M | $17.82B |
| FY 2024 | $37.7M | $56.33B | 19.2% | 70.0% | -$13.5M | $17.83B |
| FY 2023 | $36.7M | $54.32B | — | — | -$18.8M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TKNO // BETA —
ABBV // BETA 1.15